About Abseil Pharmaceuticals Private Limited
Data last updated:
Abseil Pharmaceuticals Private Limited is a private limited company based in Burdwan, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 January 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U24233WB2014PTC199680. Its GSTIN is 19AAMCA3699J1ZX (West Bengal).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Nabarun Das and Madan Pandit.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Burdwan, West Bengal.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.66 Cr, a growth of 26% compared to the previous year. For the same year it recorded a net profit of ₹12.19 Lakh (net margin 2.2%) and EBITDA of ₹26.77 Lakh (EBITDA margin 4.7%). Revenue has grown at a compounded annual rate (CAGR) of 37% over three years and 23% over five years.
The company has about 25 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.65 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website abseil.in.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressUttarabus Cum Truck Terminal And Commercial Comple Block D Room No.Sd 219 1st Floor Nawa, Bhat, Burdwan, West Bengal, India – 713101
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Abseil Pharmaceuticals Private Limited
The main business activity of Abseil Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Abseil Pharmaceuticals Private Limited
Abseil Pharmaceuticals Private Limited is audited by J K S S & ASSOCIATES for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| J K S S & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Abseil Pharmaceuticals Private Limited
Abseil Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nabarun Das | Director | 15 Jan 2015 | 11 Years 8 Months | Current |
| Madan Pandit | Director | 21 Jan 2014 | 12 Years 8 Months | Current |
| Tanmoy Pathak | Director | 21 Jan 2014 | 12 Years 8 Months | Current |
Financials of Abseil Pharmaceuticals Private Limited FY 2025 filings available
Abseil Pharmaceuticals Private Limited reported revenue of ₹5.66 Cr (up 26% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Abseil Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 23% over five years, including 26% growth in the latest year. EBITDA rose 53% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Abseil Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹26.77 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹12.19 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Abseil Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.7% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 2.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Abseil Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Abseil Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Abseil Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Dec 2024 | Others | ₹7.4 Lakh | Open |
| 28 Nov 2024 | Others | ₹7.43 Lakh | Open |
| 24 Jun 2020 | Others | ₹1.5 Cr | Open |
Total charge records: 3 View all charges
Employees and EPFO Compliance at Abseil Pharmaceuticals Private Limited
Abseil Pharmaceuticals Private Limited has a workforce of 25 employees as of Mar 28, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Abseil Pharmaceuticals Private Limited
Abseil Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAMCA3699J1ZX | West Bengal | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Abseil Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Abseil Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Abseil Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Abseil Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Abseil Pharmaceuticals Private Limited
Frequently Asked Questions about Abseil Pharmaceuticals Private Limited
Abseil Pharmaceuticals is an active private limited company based in Burdwan, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 January 2014 (12+ years old) and is registered under CIN U24233WB2014PTC199680.
Abseil Pharmaceuticals reported revenue of ₹5.66 Cr for FY 2024 (up 26% YoY).
Abseil Pharmaceuticals has 3 current directors:
- Nabarun Das - Director
- Madan Pandit - Director
- Tanmoy Pathak - Director
Abseil Pharmaceuticals reported a net profit of ₹12.19 Lakh (net margin 2.2%) and EBITDA of ₹26.77 Lakh (EBITDA margin 4.7%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Abseil Pharmaceuticals is 37% over three years and 23% over five years. In the latest year (FY 2024) revenue rose 26%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Abseil Pharmaceuticals is 19AAMCA3699J1ZX, registered in West Bengal.
The CIN (Corporate Identification Number) of Abseil Pharmaceuticals is U24233WB2014PTC199680. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Abseil Pharmaceuticals was incorporated on 21 January 2014, making it 12+ years old. It is registered with the Registrar of Companies, Kolkata.
Abseil Pharmaceuticals can be reached through the website abseil.in. Its registered office is in Burdwan, West Bengal, India.